» Articles » PMID: 31371738

Inhibition of Snake Venom Induced Sterile Inflammation and PLA2 Activity by Titanium Dioxide Nanoparticles in Experimental Animals

Overview
Journal Sci Rep
Specialty Science
Date 2019 Aug 3
PMID 31371738
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Sterile inflammation (SI) is an essential process in response to snakebite and injury. The venom induced pathophysiological response to sterile inflammation results into many harmful and deleterious effects that ultimately leads to death. The available treatment for snakebite is antiserum which does not provide enough protection against venom-induced pathophysiological changes like haemorrhage, necrosis, nephrotoxicity and often develop hypersensitive reactions. In order to overcome these hindrances, scientists around the globe are searching for an alternative therapy to provide better treatment to the snake envenomation patients. In the present study TiO (Titanium dioxide)-NPs (Nanoparticles) has been assessed for antisnake venom activity and its potential to be used as an antidote. In this study, the synthesis of TiO-NPs arrays has been demonstrated on p-type Silicon Si < 100 > substrate (∼30 ohm-cm) and the surface topography has been detected by Field-emission scanning electron microscopy (FESEM). The TiO-NPs successfully neutralized the Daboia russelii venom (DRV) and Naja kaouthia venom (NKV)-induced lethal activity. Viper venom induced haemorrhagic, coagulant and anticoagulant activities were effectively neutralized both in in-vitro and in vivo studies. The cobra and viper venoms-induced sterile inflammatory molecules (IL-6, HMGB1, HSP70, HSP90, S100B and vWF) were effectively neutralised by the TiO-NPs in experimental animals.

Citing Articles

The Role of Snake Venom Proteins in Inducing Inflammation Post-Envenomation: An Overview on Mechanistic Insights and Treatment Strategies.

Rao S, Reghu N, Nair B, Vanuopadath M Toxins (Basel). 2024; 16(12.

PMID: 39728777 PMC: 11728808. DOI: 10.3390/toxins16120519.


Proteomic diversity of Russell's viper venom: exploring PLA2 isoforms, pharmacological effects, and inhibitory approaches.

Srinivasan K, Nampoothiri M, Khandibharad S, Singh S, Nayak A, Hariharapura R Arch Toxicol. 2024; 98(11):3569-3584.

PMID: 39181947 PMC: 11489194. DOI: 10.1007/s00204-024-03849-5.


Inhibition of the venom toxicity by polymeric nanoparticles loaded with methanolic extract.

Singh P, Jayaraman G Front Pharmacol. 2024; 15:1385213.

PMID: 38783952 PMC: 11112068. DOI: 10.3389/fphar.2024.1385213.


Self-therapeutic metal-based nanoparticles for treating inflammatory diseases.

Han R, Xiao Y, Bai Q, Choi C Acta Pharm Sin B. 2023; 13(5):1847-1865.

PMID: 37250153 PMC: 10213990. DOI: 10.1016/j.apsb.2022.07.009.


Inflammation and Oxidative Stress in Snakebite Envenomation: A Brief Descriptive Review and Clinical Implications.

Resiere D, Mehdaoui H, Neviere R Toxins (Basel). 2022; 14(11).

PMID: 36422976 PMC: 9694585. DOI: 10.3390/toxins14110802.


References
1.
Sutherland S . Serum reactions. An analysis of commercial antivenoms and the possible role of anticomplementary activity in de-novo reactions to antivenoms and antitoxins. Med J Aust. 1977; 1(17):613-5. View

2.
Chen X, Mao S . Titanium dioxide nanomaterials: synthesis, properties, modifications, and applications. Chem Rev. 2007; 107(7):2891-959. DOI: 10.1021/cr0500535. View

3.
Alam M, Gomes A . An experimental study on evaluation of chemical antagonists induced snake venom neutralization. Indian J Med Res. 1998; 107:142-6. View

4.
Longbottom J, Shearer F, Devine M, Alcoba G, Chappuis F, Weiss D . Vulnerability to snakebite envenoming: a global mapping of hotspots. Lancet. 2018; 392(10148):673-684. PMC: 6115328. DOI: 10.1016/S0140-6736(18)31224-8. View

5.
Theakston R, REID H . Development of simple standard assay procedures for the characterization of snake venom. Bull World Health Organ. 1983; 61(6):949-56. PMC: 2536230. View